Antioxidant agent Probucol beneficial influence on incidence and severity of coronary artery restenosis after transluminal balloon coronary angioplasty
Aim. To study perspectives of reducing incidence and severity of coronary artery (CA) restenosis by adding a low dose of antioxidant agent Probucol (250 mg/d) to the treatment before and after transluminal balloon coronary angioplasty (TBCA). Material and methods. The study included 81 patients (mea...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2006-10-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1293 |
| Summary: | Aim. To study perspectives of reducing incidence and severity of coronary artery (CA) restenosis by adding a low dose of antioxidant agent Probucol (250 mg/d) to the treatment before and after transluminal balloon coronary angioplasty (TBCA). Material and methods. The study included 81 patients (mean age 55±6,5 years in Probukol group; 53±6 years in control group; total cholesterol (TCH) level – 6,2±0,66 mmol/l and 6,77±0,79 mmol/l, respectively) with chronic coronary heart disease (CHD), who underwent TBCA and coronaroangiography (CAG) 6 months later. The angiograms were assessed by quantitative computer analysis. Results. In atherosclerosis patients, antioxidant agent Probucol was highly effective not only in the lipid-lowering dose (1000 mg/d), but also in a four-fold reduced dose (250 mg/d). After six-month Probucol treatment (250 mg/d), restenosis incidence was just 19%, comparing to 28% in the control group. In Probucol group, minimal CA lumen diameter was significantly greater, and CA stenosis severity – significantly lower than in control group. Conclusion. The results obtained proved the possibility to reduce restenosis severity by Probucol treatment, even in low dose (250 mg/d), without affecting lipid profile. |
|---|---|
| ISSN: | 1728-8800 2619-0125 |